Know Cancer

or
forgot password

    • cancer clinical trials in sacramento, CA

    • S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    University of California Davis Cancer Center
    Sacramento, California 95817
    Sarcoma
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    University of California Davis Cancer Center, Division of Hematology-Oncology
    Sacramento, California 95817
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Kaiser Permanente Medical Center - Oakland
    Leukemia
    Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
    Kaiser Permanente Medical Center - Oakland
    Sacramento, California 95825
    Sarcoma
    Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
    Kaiser Permanente Medical Center - Oakland

    Trial Locations
    Kaiser Permanente Medical Center - Oakland
    Kaiser Permanente Medical Center - Sacramento
    South Sacramento Kaiser-Permanente Medical Center
    Breast Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Mercy General Hospital
    Sacramento, California 95819
    Pancreatic Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    University of California Davis Cancer Center

    Trial Locations
    University of California Davis Cancer Center
    Radiological Associates of Sacramento Medical Group, Incorporated
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
    Radiation Oncology Center
    Sacramento, California 95816
    Esophagitis, Pneumonitis, Non-Small Cell Lung Carcinoma
    Clinical Trial in Patients With Metastatic Colorectal Cancer
    Mercy General Hospital
    Sacramento, California 95819
    Colon Cancer, Rectal Cancer
    Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer
    Radiological Associates of Sacramento
    Sacramento, California 95816
    Breast Cancer, Metastases
    Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
    UC Davis Health System
    Sacramento, California 95817
    Ovarian Cancer, Primary Peritoneal Carcinoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Sutter Cancer Center
    Sacramento, California 95816
    Brain Tumor, Central Nervous System Tumor
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Mercy General Hospital
    Lung Cancer
    XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
    UC Davis Medical Center, Division of Medical Oncology
    Sacramento, California 95817
    Brain Edema, Brain Tumor
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    UC Davis Cancer Center
    Sacramento, California 95817
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Esophageal Cancer
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Sutter Cancer Center
    Sacramento, California 95816
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Kaiser Permanente Medical Center - Oakland
    Sacramento, California 95825
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    University of California Davis Cancer Center
    Kaiser Permanente Medical Center - Oakland
    Brain and Central Nervous System Tumors
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    University of California Davis Cancer Center

    Trial Locations
    University of California Davis Cancer Center
    Kaiser Permanente Medical Center - Oakland
    Kaiser Permanente Medical Center - Sacramento
    South Sacramento Kaiser-Permanente Medical Center
    Breast Cancer
    Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Lung Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
    University of California Davis Cancer Center

    Trial Locations
    University of California Davis Cancer Center
    Radiological Associates of Sacramento Medical Group, Incorporated
    Mercy General Hospital
    Head and Neck Cancer
    S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Breast Cancer
    Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer
    University of California Davis Cancer Center Dept. of UC Davis Cancer (3)
    Sacramento, California 95817
    Brain Metastasis, Non-small Cell Lung Cancer
    An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
    UC Davis Medical Center, Division of Medical Oncology
    Sacramento, California 95817
    Brain Edema, Brain Tumor
    XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
    UC Davis Medical Center
    Sacramento, California 95817
    Brain Edema, Brain Tumor
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    University of California Davis Cancer Center
    Sacramento, California 95817
    Malignant Mesothelioma
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    UC Davis Cancer Center
    Sacramento, California 95817
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.
    University of California, Davis
    Sacramento, California 95818
    Kidney Cancer, Ureteral Cancer, Prostate Cancer, Nephrolithiasis
    S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Lung Cancer
    Effects of GCP on Prostate Cancer.
    University of California, Davis
    Sacramento, California 95818
    Prostate Cancer
    Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma
    Novartis Investigative Site
    Sacramento, California 95817
    Hepatocellular Carcinoma
    DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
    Sutter Cancer Center

    Trial Locations
    Sutter Cancer Center
    UCD Cancer Center-Clinical Trials
    Prostate Cancer
    Coaching to Improve Care of Cancer Pain
    UC Davis Cancer Center
    Sacramento, California 95817
    Pain
    S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    University of California Davis Cancer Center
    Sacramento, California 95817
    Lung Cancer
    Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
    Kaiser Permanente
    Sacramento, California
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
    University of California Davis Medical Center
    Sacramento, California 95817
    Tumors
    Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer
    University of California Davis
    Sacramento, California 95817
    Carcinoma, Small Cell, Small Cell Lung Cancer
    Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
    University of California, Davis
    Sacramento, California 95818
    Priapism, Anemia, Sickle Cell